Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Proof-of-Concept, Double-blind, Randomized, Placebo-controlled Study of Ganaxolone in Posttraumatic Stress Disorder.

Next Previous
Search
Trial Profile

A Proof-of-Concept, Double-blind, Randomized, Placebo-controlled Study of Ganaxolone in Posttraumatic Stress Disorder.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jan 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ganaxolone (Primary)
  • Indications Post-traumatic stress disorders
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Marinus Pharmaceuticals

    • Most Recent Events

    • 01 Aug 2017 Based on the observed general safety of ganaxolone, the upper end of the age range for study eligibility was increased from 55 to 65 years on February 22, 2013, after which an additional 18 participants included in the modified intent-to-treat sample were recruited.
    • 01 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Jan 2014 Planned End Date changed from 1 Feb 2014 to 1 Mar 2014, according to ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top